Last synced on 17 January 2025 at 11:05 pm

Neuraxial Administration Set - Intrathecal Delivery

Page Type
Product Code
Definition
Neuraxial Administration Sets used to deliver fluids to the intrathecal space.
Physical State
Administration sets are made of polymers and connected to infusion pumps or medication containers such as syringes or flexible medication containers.
Technical Method
Administration sets are made of polymers, are connected to infusion pumps or medication containers (i.e. syringes, flexible medication containers), and are used to deliver fluids from the storage container or pump into the intrathecal space. These sets may include ANSI/AAMI/ISO 80369-6:2016 compliant neuraxial connectors.
Target Area
intrathecal space
Regulation Medical Specialty
General Hospital
Review Panel
General Hospital
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
880.5440
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 880.5440 Intravascular administration set

§ 880.5440 Intravascular administration set.

(a) Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.

(b) Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.

[45 FR 69682, Oct. 21, 1980, as amended at 66 FR 15798, Mar. 21, 2001]

Neuraxial Administration Set - Intrathecal Delivery

Page Type
Product Code
Definition
Neuraxial Administration Sets used to deliver fluids to the intrathecal space.
Physical State
Administration sets are made of polymers and connected to infusion pumps or medication containers such as syringes or flexible medication containers.
Technical Method
Administration sets are made of polymers, are connected to infusion pumps or medication containers (i.e. syringes, flexible medication containers), and are used to deliver fluids from the storage container or pump into the intrathecal space. These sets may include ANSI/AAMI/ISO 80369-6:2016 compliant neuraxial connectors.
Target Area
intrathecal space
Regulation Medical Specialty
General Hospital
Review Panel
General Hospital
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
880.5440
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 880.5440 Intravascular administration set

§ 880.5440 Intravascular administration set.

(a) Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.

(b) Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.

[45 FR 69682, Oct. 21, 1980, as amended at 66 FR 15798, Mar. 21, 2001]